---
id: "entity-moderna-d1"
type: "entity"
source_timestamps: ["§ Type 2: Option Value"]
tags: ["pharma", "case-study", "internal-tools"]
related: ["concept-option-value-investment", "entity-stephane-bancel"]
entityType: "organization"
canonicalName: "Moderna"
aliases: []
sources: ["spine"]
sourceVaultSlug: "hbr-seg-spine"
originDay: 1
articleStem: "hbr-edu-47-5-types-ai-investment"
sourceUrl: "https://hbr.org/2026/06/the-5-types-of-ai-investment-and-how-to-capture-their-value"
sourceTitle: "The 5 Types of AI Investment–and How to Capture Their Value"
---
# Moderna

**Role in this source:** the primary example of a [[concept-option-value-investment|Type 2: Option Value]] AI investment.

In 2023, Moderna deployed an internal platform called **mChat** (built on ChatGPT Enterprise) to its **3,000 employees**, achieving **80% adoption**, and subsequently built **over 750 custom GPTs**. No single GPT was a breakthrough, but collectively they built massive institutional fluency — positioning CEO [[entity-st-phane-bancel|Stéphane Bancel's]] target of bringing **15 new products to market in five years with ~6,000 staff** (a goal traditionally requiring ~100,000).

**Canonical reference.** Moderna's AI/innovation communications are the canonical reference for the mChat deployment. Per the enrichment overlay, the adoption and GPT-count details are plausible but not fully verified from the search set.